High Levels of C5a Are Associated With Reduced Macular Sensitivity in Patients With Myeloproliferative Neoplasms
Investigative Ophthalmology & Visual Science · 2025
DOI: 10.1167/iovs.66.2.41 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, 2025. Verfasst von Kathrine Gotfredsen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Zealand University Hospital, Roskilde, Denmark. Hauptthemen laut MEDLINE: Complement C5a, Myeloproliferative Disorders, Macula Lutea, Macular Degeneration. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
Previous findings indicate that patients with myeloproliferative neoplasms (MPN) exhibit elevated levels of inflammatory biomarkers and have a high prevalence of AMD. In this study, we aim to determine whether drusen and systemic inflammation in patients with MPN affect macular sensitivity in the same manner as in patients with AMD.
Methods
The study was conducted as a prospective cross-sectional study. A total of 139 study eyes of 71 patients were included in this study. We measured macular sensitivity using microperimetry and extracted blood samples to evaluate systemic inflammation markers.
Results
Multilevel linear mixed-effect analysis did not show any difference in macular sensitivity when comparing eyes of MPN patients with AMD to those without drusen (β = -0.254, P = 0.657). However, higher levels of the complement system fragment C5a were significantly correlated with decreased total macular sensitivity (β = -0.561, P = 0.027), irrespective of the presence of drusen.
Conclusions
We found that high levels of the systemic inflammation marker C5a are associated with reduced macular sensitivity, regardless of the presence of visible degenerative changes in the macular area. These findings suggest an early contribution of the complement system to macular sensitivity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Zealand University Hospital, Roskilde, Denmark.
- Department of Ophthalmology, Odense University Hospital, Odense, Denmark.
- Department of Hematology, Zealand University Hospital, Roskilde, Denmark.
Zitieren
APA
Gotfredsen, K., Abou-Taha, A., Liisborg, C., Krogh Nielsen, M., Larsen, M. K., Skov, V., Kjær, L., Hasselbalch, H. K., & Sørensen, T. L. (2025). High Levels of C5a Are Associated With Reduced Macular Sensitivity in Patients With Myeloproliferative Neoplasms. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.2.41
Vancouver
Gotfredsen K, Abou-Taha A, Liisborg C, Krogh Nielsen M, Larsen MK, Skov V, et al. High Levels of C5a Are Associated With Reduced Macular Sensitivity in Patients With Myeloproliferative Neoplasms. Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.2.41
BibTeX
@article{Gotfredsen2025,
author = {Gotfredsen, Kathrine and Abou-Taha, Andreas and Liisborg, Charlotte and Krogh Nielsen, Marie and Larsen, Morten Kranker and Skov, Vibe and Kjær, Lasse and Hasselbalch, Hans Karl and Sørensen, Torben Lykke},
title = {High Levels of C5a Are Associated With Reduced Macular Sensitivity in Patients With Myeloproliferative Neoplasms},
journal = {Investigative Ophthalmology & Visual Science},
year = {2025},
doi = {10.1167/iovs.66.2.41}
}
EUVIMED